Abstract
Alzheimer disease (AD) is a life-limiting neurodegenerative disorder that disproportionately affects women. Indeed, sex and gender are emerging as crucial modifiers of diagnostic and therapeutic pathways in AD. This Review provides an overview of the interactions of sex and gender with important developments in AD and offers insights into priorities for future research to facilitate the development and implementation of personalized approaches in the shifting paradigm of AD care. In particular, this Review focuses on the influence of sex and gender on important advances in the treatment and diagnosis of AD, including disease-modifying therapies, fluid-based biomarkers, cognitive assessment tools and multidomain lifestyle interventional studies.
| Original language | English (US) |
|---|---|
| Article number | e0231848 |
| Pages (from-to) | 235-249 |
| Number of pages | 15 |
| Journal | Nature Reviews Neurology |
| Volume | 21 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2025 |
ASJC Scopus subject areas
- Clinical Neurology
- Cellular and Molecular Neuroscience
Fingerprint
Dive into the research topics of 'Alzheimer disease seen through the lens of sex and gender'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS